Skip to main content
Fig. 1 | Journal for ImmunoTherapy of Cancer

Fig. 1

From: Complex inter-relationship of body mass index, gender and serum creatinine on survival: exploring the obesity paradox in melanoma patients treated with checkpoint inhibition

Fig. 1

Relationship of BMI with survival and clinical benefit (a-f). Panel a shows the relationship between BMI and risk (mortality), with the risk being the lowest for overweight/Class I obese patients and the highest for underweight/normal weight patientsand panel b shows the KM plots for the identified BMI risk groups. Panel c and d shows similar findings for PFS. Panel e shows the relationship for durable clinical benefit outcome. Panel f shows the distribution of BMI in patients with and without durable clinical benefit. Note: Figures b and d excluded 3 underweight patients

Back to article page